Iradimed to Participate in ROTH Healthcare Opportunities Conference

ORLANDO, Fla., Sept. 23, 2026 /CourierPR/ -- IRADIMED CORPORATION, a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York. The company's Chief Financial Officer, Jack Glenn, will host one-on-one meetings between company management and investors at the Metropolitan Club.

Iradimed is renowned for its non-magnetic intravenous (IV) infusion pump systems, specifically designed to be safe for use during MRI procedures. The company's 3860 and 3870 systems feature a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to ensure accurate, safe, and dependable fluid delivery during various MRI procedures. These systems are crucial for critically ill patients who cannot be removed from their vital medications and for children and infants who must be sedated to remain immobile during an MRI scan.

The company's 3880 MRI-compatible patient vital signs monitoring system is another standout product. It features non-magnetic components and other special features to safely and accurately monitor a patient's vital signs during MRI procedures. The 3880 system operates reliably in magnetic fields up to 30,000 gauss, making it suitable for use virtually anywhere in the MRI scanner room. Its compact, lightweight design allows it to travel with the patient from the critical care unit to the MRI and back, increasing patient safety through uninterrupted vital signs monitoring and reducing the time critically ill patients are away from critical care units.

The 3880 system includes advanced features such as wireless ECG with dynamic gradient filtering, wireless SpO2 using Masimo® algorithms, non-magnetic respiratory CO2, invasive and non-invasive blood pressure monitoring, patient temperature monitoring, and an optional advanced multi-gas anesthetic agent unit with continuous Minimum Alveolar Concentration measurements. This comprehensive system ensures effective communication of patient vital signs information to clinicians, enhancing overall patient care during MRI procedures.

Iradimed's commitment to innovation and patient safety is evident in its suite of MRI-compatible medical devices. By participating in the 5th Annual ROTH Healthcare Opportunities Conference, the company aims to strengthen its relationships with investors and showcase its cutting-edge solutions in the medical imaging industry.